Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma episode artwork

EPISODE · Mar 2, 2026 · 20 MIN

Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma

from Neuro-Oncology: The Podcast · host Drs. Maya Graham, Lauren Schaff

Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026.

NOW PLAYING

Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma

0:00 20:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 20 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on March 2, 2026.

What is this episode about?

Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!